2-[1-ethyl-2-[(E)-oct-4-enyl]-4,5-dihydroimidazol-1-ium-1-yl]ethanol
C15H29N2O+ — CID 101329730
Data last refreshed: (MolForge compound catalog, from PubChem)
About 2-[1-ethyl-2-[(E)-oct-4-enyl]-4,5-dihydroimidazol-1-ium-1-yl]ethanol
2-[1-ethyl-2-[(E)-oct-4-enyl]-4,5-dihydroimidazol-1-ium-1-yl]ethanol (PubChem CID 101329730) has the molecular formula C15H29N2O+ and a molecular weight of 253.41 g/mol. Its IUPAC name is 2-[1-ethyl-2-[(E)-oct-4-enyl]-4,5-dihydroimidazol-1-ium-1-yl]ethanol.
Molecular Properties
| Compound Name | 2-[1-ethyl-2-[(E)-oct-4-enyl]-4,5-dihydroimidazol-1-ium-1-yl]ethanol |
|---|---|
| PubChem CID | 101329730 |
| Molecular Formula | C15H29N2O+ |
| Molecular Weight | 253.41 g/mol |
| Exact Mass | 253.23 |
| IUPAC Name | 2-[1-ethyl-2-[(E)-oct-4-enyl]-4,5-dihydroimidazol-1-ium-1-yl]ethanol |
| SMILES | CCC/C=C/CCCC1=NCC[N+]1(CC)CCO |
| InChI | InChI=1S/C15H29N2O/c1-3-5-6-7-8-9-10-15-16-11-12-17(15,4-2)13-14-18/h6-7,18H,3-5,8-14H2,1-2H3/q+1/b7-6+ |
| InChIKey | BTTRCAJQTUWIFZ-VOTSOKGWSA-N |
| XLogP | 2.75 |
| TPSA | 32.59 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 2 |
| Rotatable Bonds | 9 |
| Heavy Atoms | 18 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 253.41 |
| LogP ≤ 5 | 2.75 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 2 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}, {'alert_name': 'isolated_alkene', 'substructure': 'N/A'}, {'alert_name': 'quaternary_nitrogen_2', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 101329730 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.